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This review reported notable advances in pediatrics that have been published in 2018. We have highlighted
progresses in allergy, cardiology, critical care, endocrinology, hereditary metabolic diseases, gastroenterology,
infectious diseases, neonatology, nutrition, respiratory tract disorders and surgery. Many studies have informed on
epidemiologic observations. Promising outcomes in prevention, diagnosis and treatment have been reported. We
think that advances realized in 2018 can now be utilized to ameliorate patient care.
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Numerous impressive papers were published in the Ital-
ian Journal of Pediatrics in 2018. This review presents
the most accessed articles published over the last year.
The most recent relevant updates on allergy, cardiology,
critical care, endocrinology, hereditary metabolic dis-
eases, gastroenterology, infectious diseases, neonatology,
nutrition, respiratory tract disorders and surgery in
childhood have been highlighted. Information are also
provided to contextualize each article. We believe that
this review will help readers to understand novel ad-
vances in pediatrics and to provide the best patient care.© The Author(s). 2019 Open Access This artic
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/ze
* Correspondence: carlo.caffarelli@gmail.com
1Clinica Pediatrica, Department of Medicine and Surgery, Azienda
Ospedaliera-Universitaria, University of Parma, Via Gramsci 14, Parma, Italy
Full list of author information is available at the end of the articleReview
Allergy and respiratory tract disorders
1- risk factors for atopic diseases 2-acute asthma treatment
3-provocation challenge to drugs
Asthma, food allergy [1] and atopic diseases are com-
mon in Western countries, particularly in immigrants.
Along this line, prevalence of allergen sensitization was
higher in adopted children from developing countries
with lower prevalence of atopy than in non-adopted
children in Italian population [2]. These findings under-
line that environmental factors can predispose to the
development of atopic disease in immigrants, even if
sensitization is not always associated with clinical hyper-
sensitivity reactions [3]. A key environmental risk factor
for atopy in immigrants is bad housing [4]. Additional
studies are needed to identify immigrants at risk for
atopic diseases and which factors are involved with aim
of identifying preventive intervention.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Caffarelli et al. Italian Journal of Pediatrics          (2019) 45:126 Page 2 of 15A guideline for the management of acute asthma at-
tack in childhood was issued in the past year [5]. A
multidisciplinary panel undertook a comprehensive re-
view of the published evidence. The level of evidences
and the strength of the recommendations were provided
according to pre-established standards. Criteria for
assessing severity of asthma attack were given. Regarding
treatment, inhaled salbutamol was recommended as the
first-line treatment and systemic steroids should be
added when necessary. Epinephrine injections do not
control symptoms better than β2 agonist as well as in-
haled steroid compared to systemic steroids. When
treatment is not effective, iv salbutamol or iv aminophyl-
line should be given. MgSO4 or a helium-oxygen mix-
ture (70%: 30%) could be used in children who do not
respond. Leukotriene modifiers are unhelpful. Bio-
markers for starting or discontinuing treatment during
asthma attack are warranted. Among them, levels of pH
in exhaled breath condensate may be helpful [6]. There
is some evidence of inflamed airway in children with
atopic eczema who do not suffer from asthma [7]. It
may be possible that the detection of inflammatory
markers may be useful for identifying who are at risk of
asthma exacerbation. Controllers, mainly inhaled corti-
costeroids, are used for keeping allergic asthma under
control, preventing asthma attacks, enhancing quality of
life and bringing to an end the decay of lung function.
Studies continue to highlight the role of aeroallergens
[8] and food allergens [9] in eliciting asthma attacks. So,
allergen-specific immunotherapy (AIT) should be con-
sidered in children with allergic asthma when daily
pharmacotherapy does not achieve a satisfactory
asthma control [10]. AIT is recommended in children
with asthma due to house dust mite to reduce symp-
toms and drug consumption, Both subcutaneous and
sublingual AIT have been also shown to ameliorate
allergic rhinitis or rhino-conjunctivitis with/without
allergic asthma to pollens such as grass or birch
pollen and prevent asthma onset in children [11]. Of
note, clinical benefits are maintained for years follow-
ing AIT cessation. Furthermore, there are some evi-
dence that sublingual AIT to mites can be of benefit
not only in children with atopic respiratory diseases
but also in children with atopic eczema [12]. Provoca-
tion challenge to antibiotics and non-steroidal anti-
inflammatory drugs is often necessary to diagnose
IgE-mediated and delayed reactions and to remove
drug allergy label. A document reporting indication,
contraindication and protocols for provocation test
that are extremely useful in practice, has been pro-
vided [13]. This paper reflects current knowledge on
the issue. It updates previous position papers taking
into account expanding knowledge and experience in
addressing diagnosis of drug allergy [14–17].Cardiology
1- Kawasaki disease
Kawasaki disease (KD) is an acute systemic vasculitis, that
may involve small and medium vessels in each organ and
apparatus with a multi-factorial etiology, and affects
children < 5 years of age in 80% of cases and it is generally
attributed to an amplified immunologic response to un-
known environmental or infectious triggers [18] among
genetically susceptible children [19]. Marchesi A et al. [20,
21] representing the Italian Society of Pediatrics provided
recommendations on recognition and management of KD.
The course of KD can be distinguished in three phases:
acute phase, with fever, bilateral conjunctivitis without ex-
udate, erythema of oral mucosa, erythema of the palms
and soles, polymorphic skin rash, cervical lymphadenop-
athy lasting 2 weeks; subacute phase, characterized by
digital skin desquamation, thrombocytosis, possible cor-
onary artery aneurysms (CAA) (third and fourth week);
convalescence phase, normal inflammatory indexes, per-
sisting endothelial dysfunction (fifth to eighth week). The
treatment of acute phase of KD aims at reducing the
inflammation and decreasing the risk of CAA with high-
dose intravenous immunoglobulin (IVIG) and acetylsali-
cylic acid [22]. However, 10–20% of patients do not
respond to initial IVIG, and additional therapies are
recommended. Complications of KD can be distinguished
in: resistant forms; recurrent forms; cardiovascular/sys-
temic complications. Therapies of resistant forms have
been revised particularly concerning corticosteroids and
biological drugs, of coronary artery thrombosis and car-
diovascular complication with anticoagulant drugs and
anti-platelets [23]. Moreover, the follow-up and the pre-
vention techniques have been pointed out, according to
cardiovascular risk classes with short- and long-term rec-
ommendations. Regarding cardiovascular complications,
myocarditis may be involved in the acute phase without
differences between patients affected or not by CAA [24].
Clinical signs and symptoms of KD vary from asymptom-
atic to hyperdynamic precordium, hemodynamic instabil-
ity and ventricular dysfunction that may necessitate fluid
resuscitation and vasoactive treatment. Among cardiovas-
cular events, also myocarditis may occur and its diagnosis
needs to be sustained by imaging (nuclear imaging, echo-
cardiography, magnetic resonance), serum biomarkers and
biopsy. Long-term clinical consequences of myocardial in-
flammation, although rare, can appear in the setting of
CAA. Echocardiography represents the gold-standard to
identify CAA during the acute phase of KD [25]. Recently
it has been adopted an international coronary artery z
score with the measurement of the coronary artery diam-
eter and the body surface area, that permits to define
ectasia, slight expansion (diameter < 5mm), moderate
dilatation (5–8mm), and giant aneurysm (> 8mm) [22].
Echocardiography should be performed at the diagnosis
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uncomplicated cases without important coronary artery
involvement [25]. Standardized imaging protocols are
needed for diagnosis and follow-up of cardiovascular
events in KD.
Critical care
1 - pediatric head injury 2 - vitamin K deficiency
In developed countries the most common causes for pres-
entation to the emergency department (ED) among
children are injuries, that represent a frequent source of
disability and death. The Italian Society of Pediatric
Emergency Medicine has published a guideline on
pediatric head injury to help ED physicians in treating
children with a blunt head trauma [26]. The initial assess-
ment of stabilization in children with severe head trauma
include the ABCDE approach: Airway with cervical spine
protection; Breathing; Circulation (hemorrhage control);
Disability (neurologic status); Exposure (undress) and
Environment (temperature control). Cchildren with head
trauma should be monitored within the first 24 h of their
injury. The diagnosis of clinically important traumatic
brain injury includes the age appropriate PECARN algo-
rithms to assist the decision to perform a head CT scan in
children with a GCS < 14. In children with severe blunt
head trauma and signs of raised intracranial pressure it
should be administered hyperosmolar treatment with
hypertonic saline [27]. Hhyperventilation, except those
with signs of impending cerebral herniation, in which rep-
resents a life-saving action should be avoided.
The deficiency of vitamin K causes a disorder of
hemostasis, called vitamin K deficiency bleeding (VKDB),
that typically occurs in the postnatal period. Therefore, in
order to prevent VKDB at birth all neonates receive vita-
min K prophylaxis with 1mg intramuscularly or 2mg or-
ally. Three forms can be distinguished: early VKDB, that
occurs in the first 24 h of life; classic VKDB, from the first
to 7 days after birth; late form, between the 2nd and the
6th weeks of life. Hemorrhagic manifestations are usually
gastrointestinal and cutaneous, or additionally cerebral in
late forms. Infants with late VKDB presented with neuro-
logical signs [28] or with bleeding of the skin at the vac-
cine site [29]. Both neonates received oral vitamin K
prophylaxis at birth. However, oral route can be affected
by different irregularities of absorption, such as absorp-
tion, unknown cholestasis, vomiting, setting. According to
recent studies and international guidelines, intramuscular
administration of vitamin K is clinically more effective
than oral one especially in late forms, so it should be pre-
ferred at birth [30, 31]. The administration of oral 2 mg
vitamin K at birth, repeated twice at 2–4 and 6–8 weeks of
age, should be limited to newborns whose parents decline
intramuscular vitamin K [32]. Moreover, it has been pro-
posed to increase the dose of vitamin K prophylaxis with a6-fold increase of daily regimen, demonstrating a signifi-
cant although modest reduction of intracranial VKDB in a
Dutch nationwide survey [33]. Univocal recommendations
about vitamin K administration at birth should be given.Endocrinology
1 - vitamin D 2 - hypothyroidism 3- premature pubarche
In recent years, many studies have been published on the
role that vitamin D plays in various physio-pathological
conditions. This renewed interest arises from several fac-
tors: the reappearance of rickets especially in less privi-
leged populations even after a prophylaxis applied for
years that had made the disease disappear [34], the results
of epidemiological studies in different Countries showing
non optimal blood levels of 25 (OH) D in many childhood
populations, even in those living in economically well-
developed societies, and finally the discovery that the vita-
min has a pleiotropic action and may therefore interfere
in various biological mechanisms, not only on bone
health.
However, the results obtained thus far have not made
it possible to reach definitive and universally accepted
conclusions.
Even the definition of optimal blood levels is a source
of discussion among those who believe that a level of 20
ng/ml is sufficient for normal bone growth (although
this figure is mainly acquired from the experience in
adults) and those who deem necessary levels of at least
30 ng/ml considering the pleiotropic potential of the
vitamin.
It is therefore useful that groups of pediatric specialists
in various Countries carry out a careful review of litera-
ture, taking into account local realities, in order to sug-
gest shared behaviors to family pediatricians.
In this sense, the recently published Italian Consensus
[35] that recommends the dose of vitamin D in the vari-
ous age groups is extremely useful, also considering re-
cent dietary surveys which showed insufficient vitamin
supplementation during the first years of life [36].
Among the possible extra skeletal actions of vitamin D
numerous researches have tried to determine if there is
a role in the pathogenesis of autism.
Low blood levels of 25-hydroxy vitamin D have been
found in a group of children with autism spectrum dis-
order (ASD) living in Ahvaz, a city in the southwest of
Iran [37]. This result is in agreement with a recent
meta-analysis [35] which showed that serum 25(OH) D
levels were significantly lower in children and adoles-
cents with ASD than in controls.
The possible role of 25(OH) D in ASD pathogenesis has
been matter of discussion for many years but no definitive
conclusion or general agreement has been achieved. Epi-
demiological studies have shown a dramatically increased
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cribed to environmental factors.
In fact, there is a general agreement on the hypothesis
that the interaction between genetic and environmental
factors causes most ASD [38]. Among these environmen-
tal factors 25(OH) D may play a pivotal role through sev-
eral mechanisms which have been extensively reviewed
[38]. In particular, calcitriol (the activated vitamin D hor-
mone) is considered a neurosteroid hormone capable of
protecting brain tissue by reducing inflammatory cytokine
levels.
The translation of experimental data into clinical prac-
tice is however open to different opinions.
The Authors of the Italian consensus on vitamin D
[35] concluded that further research is needed before
recommending routine vitamin D supplementation in
children with ASD. However, some Authors conclude
that although scientific data on the role of vitamin D in
the prevention or treatment of autism is preliminary,
this does not relieve practitioners from using all current
available scientific evidence to make a risk benefit ana-
lysis of whether or not to treat or supplement their pa-
tients with vitamin D up to 40–60 ng/ml, levels
recommended by the Endocrine Society [38].
A third paper published on the Italian Journal of
Pediatrics drew attention to an aspect that has not been
studied in depth. Doneray et al. concluded that maternal
and neonatal vitamin D-binding protein (DBP) levels may
lead to an incorrect low estimate of true Vitamin D con-
centrations [39]. The major circulating form of vitamin D
is 25-hydroxyvitamin D (25(OH)D). In the circulation,
vitamin D (like other steroid hormones) is tightly bound
to a special carrier – vitamin D-binding protein (DBP).
Smaller amounts are bound to blood proteins – albumin
and lipoproteins. Only very tiny amounts of total vitamin
D are free and potentially biologically active. Currently
used vitamin D assays do not distinguish between the
three forms of vitamin D – DBP-bound vitamin D,
albumin-bound vitamin D, and free biologically active
vitamin D. Sex steroids, in particular estrogens, stimulate
the synthesis of DBP. This explains why total vitamin D
concentrations are higher during pregnancy as compared
to nonpregnant women, while the concentrations of free
vitamin D remain similar in both groups of women [40].
The free hormone hypothesis postulates that only free
25(OH) D can enter cells. This hypothesis is supported by
the observation that mice lacking DBP, and therefore with
essentially undetectable 25(OH) D levels, do not show
signs of vitamin D deficiency unless put on a vitamin D
deficient diet. This hypothesis also applies to other protein
bound lipophilic hormones including glucocorticoids, sex
steroids, and thyroid hormones [41].
Further studies are therefore necessary to understand
whether the dosage of binding protein and the freefraction of the vitamin can provide us with further infor-
mation in terms of pathogenesis of various diseases and
help to better define vitamin needs in the individual.
The need to find validated and widely available labora-
tory methods that allow a correct determination of these
parameters should also be considered.
Gallizzi et al. [42] reviewed the main clinical and
metabolic abnormalities that might be observed in
children with longstanding and untreated subclinical
hypothyroidism (SH). They highlighted that there is no
evidence of any neurocognitive outcome, except for the
attention level. L-T4 treatment does not seem to be able
to improve the attention problems. Linear growth, height,
growth velocity or bone maturation, bone mineral homeo-
stasis are not affected [43]. Hyperthyrotropinemia should
be considered a consequence rather than the cause of
obesity in overweight children with SH, supposing that
this condition might play a key role in conditioning the
risk of Metabolic Syndrome. Children with mild and un-
treated SH might have an increased cardiovascular risk
because this condition is related to early changes in
proatherogenic profile (increased concentrations in asym-
metric dimethylarginine, marker of endothelial dysfunc-
tion) [44], particularly in obese children. SH should be
treated [45] according to patient’s age, with TSH values>
10 uUI/ml, for progressively increasing TSH serum levels
or according to the presence of Hashimoto Thyroiditis.
Many studies have been published on the higher risk
of insulin resistance, obesity and later Metabolic Syn-
drome or PCOS in children with premature adrenarche,
probably caused by the influence of adrenal androgens
(DEA, DHEAS, 17OH pregnenolone, 17OH progester-
one) on glucose homeostasis and on ovarian function
[46, 47]. In order to detect predictive factors of prema-
ture pubarche, Cavarzere et al. published the first study
analysing the relation between premature pubarche and
the 17OHP level at newborn screening for CAH [48].
They found no correlation between elevated 17OHP
levels at screening and the development of premature
pubarche, excluding the utility of this value in predicting
it.They recommended making all confirmatory tests in
children with elevated 17OHP levels at screening only
later on, if further symptoms appear. Among children
with precocious pubarche ACTH test should be per-
formed when ratio between bone age and statural age
exceeds 1 and/or elevated androgen levels for age or cys-
tic acne or other signs of systemic virilization, in order
to identify also late onset CAH.
Gastroenterology
1 – functional gastrointestinal disorders; 2 – acute
gastroenteritis
Abdominal pain is present in different functional gastro-
intestinal disorders (FGIDs), particularly in irritable
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pain in FGDIs remains unclear. Dietary intervention can
play a role in non-pharmacological management of
FGIDs. Taking into account that FGIDs are not associ-
ated with immunologically mediated reactions to foods
[49] a diet free of common allergens usually fails and it
has been abandoned. FODMAPs are poorly absorbed
carbohydrates that are fermentable by colonic bacteria
with gas production and increase osmotic action. In the
last decade, a low fermentable oligosaccharides, disac-
charides, monosaccharides, and polyol (FODMAPs) diet
has been increasingly used for treating FGIDs [50–52].
Turco R et al. [53] showed that there is evidence that a
low FODMAPs diet is of benefit in adults with IBS. In
children, further studies are warranted to clarify the effi-
cacy of a restricted diet in FODMAPs.
Acute gastroenteritis continues to be a significant
focus of research since it is a common infectious disease
in children with elevated mortality rates in developing
countries [54]. Several approaches have been proposed
for managing symptoms of acute gastroenteritis includ-
ing probiotics [55], antidiarrheal agents, antiemetic, zinc
[56]. In a randomized, case-controlled trial, natural mo-
lecular complex of tannins and flavonoids plus standard
oral rehydration (SOR) was more effective than standard
oral rehydration (SOR) alone in reducing number of
stools after 24 h of treatment [57]. The treatment was
well tolerated and safe in 30 children. Larger studies are
required on this approach [58].
Hereditary metabolic diseases
1 – clinical features; 2 - mucopolysaccharidoses
When newborns and infants experience acute or recur-
rent symptoms after food ingestion, first of all immune-
mediated adverse food reactions are considered in the
list of the possible causes, but also non-immunological
food reactions, motility disorders or anatomic abnormal-
ities of the gastrointestinal tract, infections, systemic dis-
eases, inherited metabolic disorders (IMDs) should be
included in the differential diagnosis [59].
Maines et al. report clinical features and diagnostic as-
pects of the most common IMDs that may present with
acute manifestations triggered by food intake [60].
Inherited metabolic disorders (IMDs) are a complex and
heterogeneous group of rare monogenic disorders, usu-
ally resulting from a deficient activity in a single pathway
of intermediary metabolism [61]. Each IMD is rare if
considered alone, but the cumulative incidence is esti-
mated 1:1500–5000 [62, 63]. Deficiencies of enzymes or
transporters involved in the amino acid and/or protein
metabolism may present acutely in the neonatal period
or later in life with acute, intermittent or progressive
symptoms. Catabolic states or increased protein intake
are the most common triggers that provoke acutemetabolic attacks with vomiting or feeding difficulties
accompanied by lethargy or encephalopathy that may
rapidly progress to coma, and liver failure [64]. Actually,
for many IMDs (in particular, the distal urea cycle disor-
ders, the organic acidurias, and the maple syrup urine
disease) the risk of an acute presentation triggered by
food is decreased thanks to the introduction of expanded
newborn screening (NBS). Through few laboratory data
(including ketones, ammonia and blood gas analysis)
performed during an acute attack, it is possible to pro-
vide a first differential diagnosis of IMDs triggered by
proteins. Intoxication may also be caused by toxic carbo-
hydrate metabolites derived by exogenous intake of gal-
actose and fructose, respectively [65, 66]. If galactosemia
is the underlying disorder, breastfeeding or lactose-
containing formula feeding during the first days of life
can cause severe liver dysfunction, that may present with
jaundice, hepatomegaly, hypoglycemia, coagulation dis-
turbances, and gastrointestinal findings of poor feeding,
vomiting and diarrhea. The onset of illness may be acute
and fulminant and may often be confused with neonatal
sepsis due to the E. coli infection [67]. The hereditary
fructose intolerance usually presents at the time of
weaning, when fruits and vegetables are introduced into
the diet. Acute symptoms include gastrointestinal dis-
comfort, feeding difficulties, vomiting, pallor, metabolic
acidosis, hepatomegaly, hypoglycemia, restlessness, leth-
argy and shock. Generally, these patients are asymptom-
atic since they avoid foods containing fructose or any of
its common precursors (such as sucrose and sorbitol),
while prolonged fructose ingestion can ultimately lead to
liver failure and renal dysfunction [65, 66]. In conclu-
sion, while IMDs clinical suspicion remains essential be-
cause some IMD do not have still reliable markers for
NBS and a false negative screening result may occur, on
the other hand high clinical suspicion alone is not suffi-
cient to exclude the disorder, therefore expanded NBS
needs to be considered as a mandatory public health
strategy [68]. Early diagnosis of several IMDs makes it
possible to modify their course reducing morbidity and
mortality. In a recent review Joseph et al. [69] have pro-
posed a screening test of Hunter syndrome and of
mucopolysaccharidosis type II. Smon et al. have pro-
posed to use an expanded NBS approach that includes
the next-generation sequencing (NGS) for confirming
the clinical suspicion [70]. These authors concluded that
not only NGS is valuable for explaining the abnormal
metabolite concentrations in NBS by enabling the dis-
tinction between affected individuals and mere heterozy-
gotes, but also that it improves the turnaround time of
genetic analysis.
Mucopolysaccharidoses (MPS) are a heterogeneous
group of inherited metabolic disorders, each associated
with a deficiency of the enzymes involved in the
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late in cells and tissues, with progressive damage in dif-
ferent organs that leads to premature death. The ear,
nose, and throat (ENT) manifestations in MPS, due to
the accumulation of GAGs in the head and neck region,
are very common in the MPS population [71, 72]. They
include protruding or depressed frontal bone, a de-
pressed nasal bridge, wide nasal alae, thick lips, angled
and hypoplastic mandible (micrognathia), macroglossia,
distorted teeth, gingival hypertrophy, also restriction of
the mouth opening, with moderate-to-severe adenoton-
sillary hypertrophy and thickening of the soft tissues in
the laryngopharynx. Bianchi et al. [73] have investigated
the role of otolaryngologists in the multidisciplinary ap-
proach to paediatric or adult MPS [74]. Respiratory dis-
orders occur in all type of MPS since affected individuals
classically have a number of anatomical features that
predispose to airway dysfunction [75, 76]. Airway prob-
lems include obstructive sleep apnea (OSA), frequent re-
spiratory infections, adenoid and tonsillar hypertrophy,
irregular nasal septum, turbinate hypertrophy, macro-
glossia, thickened pharyngeal wall, laryngeal abnormal-
ities, tracheomalacia, tracheal stenosis and short neck,
dyspnea, restricted joint mobility, skeletal abnormalities,
and increased mucus secretions in the upper and lower
airways [77–81]. Chronic rhinosinusitis and chronic
otitis media lead to hearing impairment [76]. Upper and
lower respiratory tract infections are frequent. Respira-
tory disorders in MPS can be divided into airway
abnormalities (extra thoracic and intrathoracic), and al-
terations in the respiratory and sleeping mechanics [82].
Extra thoracic anatomical abnormalities and GAGs infil-
tration of the nasopharyngeal, oropharyngeal, hypophar-
yngeal, and laryngeal tissues, predispose children with
MPS to severe upper airway obstruction [83]. Intratho-
racic airway obstruction is also a common complication,
and it could be complicated by tracheobronchial abnor-
malities [82]. The trachea can be narrow, tortuous, or
occluded by the accumulation of soft tissue [83]. There-
fore, most MPS patients have stridor, dyspnea, retrac-
tions, cough, cyanosis, or difficulty with feeding [84],
and the severity of respiratory dysfunction varies accord-
ing to the MPS type [83]. The combined effect of these
alterations in respiratory mechanics together with airway
abnormalities may lead to irreversible and fatal respira-
tory failure.
All MPS types may have severe or attenuated presenta-
tions, this depending on the residual enzymatic activity
found. Galimberti et al. have underlined the very early
signs of the severe forms of MPS which should alert the
paediatrician on their first appearance [85]. In the first 6
months of life, inguinal hernias, abnormally frequent re-
spiratory infections, otitis, and organomegaly can be seen
in MPS patients, particularly in MPS I (caused by adeficiency of the lysosomal hydrolase α-l-iduronidase).
Moreover, from 6 to 12months, these infants very often
develop a gibbus due to the thoraco-lumbar kyphosis,
present with mild hypotonia, and develop growth delay.
Symptoms and signs suggestive of MPS, should promptly
arouse suspicion of MPS in any infant or child presenting
with one or more of these features. Referring these pa-
tients to a specialized centre will allow the recognition of
these disorders at a very early stage. Kuiper et al. [86] have
reported on attenuated forms of MPS, and concluded that
many patients may remain apparently asymptomatic for
years and are frequently diagnosed at an advanced stage,
this confirming the relevant importance of new pilot new-
born screening programs for MPS.
Infectious diseases
1 – human immunodeficiency virus; 2 - vaccination
Human immunodeficiency virus (HIV) develops very
rapidly among infants and children. If untreated, half of
children with HIV will die before their second birthday
and one third before year one [87]. At the end of 2016,
2.1 million children younger than 15 years old were af-
fected by HIV, and more than half of them were from
sub-Saharan Africa. Undernutrition is a major public
health problem in countries with high prevalence of
HIV. Ethiopia is one of the sub-Saharan countries with
the highest prevalence of HIV, and malnutrition is fre-
quent [88]. The relationship between malnutrition and
HIV is bidirectional: on one side malnutrition acceler-
ates the progress of HIV infection, on the other, once
HIV occurs, the patient’s nutritional status declines rap-
idly and leads to immune depletion and HIV progression
[89]. In Ethiopia, although individuals are often dually
impacted, the effect of undernutrition on the survival of
HIV positive children treated with anti-retroviral therapy
(ART) has not been well investigated. Alebel et al. con-
ducted a 5-years study considering nutritional status as
an independent predictor of survival in 390 HIV positive
children treated with ART from Amhara Regional State
Referral Hospitals, Ethiopia [90]. They found an overall
mortality rate of 4.4 per 100 child-years and demon-
strated that undernourished children had a lower sur-
vival time than well-nourished peers. Moreover, as well
as severe stunting, low hemoglobin level, CD4 cell count
or percent below the threshold, severe wasting and ad-
vanced disease stage (III and IV) were found to be good
predictors of mortality. This finding is consistent with a
study conducted in Northern Ethiopia on a cohort of
149 HIV-1-infected children that showed that early mor-
tality (death < 18 months after ART initiation) was
higher than late mortality (death ≥18 months after ART
initiation) and that low baseline hemoglobin is an inde-
pendent risk factor for death [91]. Similar findings were
also reported from two other studies from Singapore
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interventions aimed at improving the nutritional status
of HIV positive children are a relevant adjunct to ART.
Vaccines are among the greatest achievements of bio-
medical science and public health [94]. Unfortunately,
vaccination is still perceived as unsafe and unnecessary
by a growing number of individuals. Vaccine hesitancy is
believed to be responsible for decreasing vaccine cover-
age and an increasing risk of vaccine-preventable disease
outbreaks and epidemics [95]. In this contest, anti-
vaccination campaigns have had a damaging impact on
vaccine uptake. In order to achieve high vaccine cover-
age, all walls that impede vaccination including allergic
reaction to a vaccine component or to a previous dose
should be eliminated [96]. Moreover, some countries
have introduced laws to require children to be vacci-
nated before school entry. Policies that mandate vaccin-
ation have always been controversial [97].
Bozzola et al. compared vaccination policies in chil-
dren under 18 months against diphtheria, tetanus, per-
tussis, hepatitis B, poliovirus, Haemophilus influenzae
type b, measles, mumps, rubella and varicella among dif-
ferent European countries [98]. They found that eleven
Countries introduced mandatory vaccination and other
recommended vaccinations. Latvia and Italy have 10
mandatory vaccines (tetanus, diphtheria, pertussis, Hae-
mophilus influenzae type B, Hepatitis B, poliovirus,
mumps, measles, rubella) in childhood. Other countries
(i.e. Bulgaria, Croatia, Czech Republic, France, Hungary,
Poland and Slovakia) have the same vaccines which are
compulsory among children, except varicella. All
European Countries recommended or introduced com-
pulsory vaccinations for the following vaccinations: tet-
anus, diphtheria, pertussis, Haemophilus influenzae type
B, hepatitis B, poliovirus, mumps, measles, rubella with
the exception of Iceland that did not recommend hepa-
titis B vaccination. This study demonstrates that many
European countries, including Italy, adopted compulsory
policies for preventing the spread of infectious diseases
and protecting the community, with encouraging results.
Studies of the impact of mandatory immunization in
high-, middle- and low-income countries in different
contexts are urgently needed as many countries have
enacted or are contemplating mandatory childhood
immunization programs [99]. Regrettably in this sce-
nario, there are still many differences between European
countries as far as the type of vaccine used, number of
doses and timing of vaccinations.
Neonatology
1 – electrolyte disturbances; 2 - neonatal intensive care; 3 -
family integrated care
Birth asphyxia is defined as the presence of hypoxia, hy-
percapnia, and acidosis leading to systemic disturbancesin newborns [100]. It is a common problem, with inci-
dence from 0.5–2% of live births [101]. There is limited
literature regarding electrolyte disturbances in asphyxi-
ated newborn, despite they significantly affect perinatal
morbidity, mortality and future management.
Thakur et al. have investigated electrolyte (sodium, po-
tassium, calcium) disturbances in asphyxiated newborns
of different severity [102]. They found that hyponatre-
mia, hyperkalemia and hypocalcemia occurring in neo-
nates with perinatal asphyxia may be responsible for
increased morbidity and mortality and that hyponatre-
mia and hyperkalemia are positively associated with the
severity of birth asphyxia, thus confirming the data from
Basu et al. [103]. In birth asphyxia the treatment of
hyponatremia includes fluid restriction, rather than in-
creased sodium load, till normalization of serum sodium
are achieved. Correction of acidosis and use of potas-
sium free fluid are the most useful measures to correct
hyperkalemia, while serum potassium and electrocardi-
ography (ECG) monitoring should be performed to
avoid the complications associated to hyperkalemia.
Families satisfaction has become an important indicator
of health care quality and patients’ opinions contribute to
measure the quality of the delivered care [104–107]. In
the Neonatal Intensive Care Units (NICU), the positive or
negative experiences of parents may influence the lives of
parents and infants over time and assessing NICU parents’
satisfaction is crucial to inform new directions for change
[108–111]. Recently, a specific instrument, the EMpower-
ment of PArents in THe Intensive Care-Neonatology
(EMPATHIC-N), has been developed in the Netherlands;
it is a validated instrument which investigates different do-
mains of care in NICUs from a family-centered care per-
spective [112]. Dall’Oglio et al. have recently translated,
cultural adapted and validated the Dutch EMPATHIC-N
instrument into Italian in order to provide a benchmark
outcome measure [113]. They conducted a multi-center
study in nine level III NICUs allocated across Italy. Par-
ents were enrolled and received the EMPATHIC-N in-
strument on the day of discharge or within the first 3 days
after the discharge of their child. Results demonstrate that
the Italian version of the EMPATHIC-N has good psycho-
metric properties, validity, and reliability showing and
that, although the environment plays an important role
for parents’ satisfaction, the behavior of the staff and the
quality of parent-provider relationship still influence par-
ents’ experience [114]. Other recent studies have con-
firmed that EMPATHIC-N is a valid and reliable measure
for the assessment of parental satisfaction in the NICUs
[112, 115, 116].
At present, the number of preterm births is rising. Pre-
term neonates are at an increased risk for a wide range
of short- and long-term respiratory, infectious, metabolic
and neurological complaints [117–119] and prematurity
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which decrease exponentially with increasing gestational
age. The WHO proposed several relevant measures to
improve the quality-of-life and health of preterm infants
which include family-centered care. Family Integrated
Care (FIC) is an approach that allows parents to provide
non-medical routine care for their preterm infant during
NICU hospitalization [120]. If greater involvement of
parents in the care of their infant is wished, the NICUs
need to be liberal in the visiting policies. Most NICUs in
China have restricted visiting policies and parents have
limited involvement in care. For this reason, He et al.
conducted a pre-post intervention study at NICUs in
two Chinese children’s hospitals including infants with
BPD subdivided into a pre-intervention (n = 134; from
December 2015 to September 2016) and a post-
intervention (FIC) group (n = 115 neonates and their
parents; from October 2016 to June 2017), with parents
asked to be present and to care for their infant not less
than 3 h per day [121]. The infants’ outcome measures
were length-of-stay, breastfeeding, weight gain, respira-
tory and oxygen support, and parent hospital expenses.
They demonstrated that the FIC model is feasible in
NICUs and might result in significant improvements of
infants’ clinical outcomes such as weight gain, breast-
feeding time, breastfeeding rate and respiratory support
time.
Neurology
1 – media device; 2 - cyberbullying; 3 - early-life seizures
Media devices (MD) are widespread today not only
among adults, as also pre-school children are growing
up in environments fool of internet connections, per-
sonal computer and video games. The percentage of
children aged 0–8 years using a mobile device increased
from 38% in 2011 to 72% in 2013 [122]. At present, al-
most all children use MD, most of kids start using a mo-
bile MD before the age of 1 year, and a lot of them use a
device daily, in particular smartphones and tablets [123].
Several studies have described the adverse effects of an
early and prolonged exposure of pre-school children to
digital technology, underlining the negative effects on
the neurocognitive development, learning, well-being,
sight and listening [124]. Bozzola et al. have investigated
both beneficial and negative effects of media on pre-
school children’s mental and physical health [125]. They
found that touch screen usage may interfere with infant
and toddler learning development. However, children
younger than 3 years old can learn words through video
if the experimenter/parent/caregiver provide additional
verbal and non-verbal information during the live action
sequences [126]. Moreover, mobile phones could
reinforce what children are already learning at school.
As far as children’s development, it is negatively affectedby the television exposure [127], while drawing apps are
appropriate for young children playing a positive role in
their development [128]. MD inappropriate use is also
associated to behavioral problems, obesity, sedentary,
and physical discomfort, especially involving neck and
shoulders [129]. Media usage may also interfere with
sleep quality, in particular the presence of a television in
the bedroom is associated with sleep terrors, nightmares
and sleep talking [130]. Excessive smartphone use at a
close reading distance might induce ocular fatigue, glare,
and irritation and be responsible for acute exotropia
[131]. Speech and language development may be com-
promised too. Difficulties in socializing, communicating
and interacting with other kids and parents may be pos-
sible side effects [132]. Paediatrician and families should
create a network to manage MD to minimize unhealthy
habits and behaviors, avoiding negative effects on health,
wellness, social and personal development [133]. Finally,
in agreement with the American Academy of Pediatrics
[123] and the Australian guidelines [134], media devices
should not be used in children under 2 years of age.
Media exposure should be limited to less than 1 h per
day in children aged 2–5 years, to less than 2 h per day
in children aged 5–8 years, to high-quality programming,
just in presence of an adult, and to apps tested by a
care-giver before the child usage.
Social media has had a profound effect on how chil-
dren and adolescents interact. While there are many
benefits to the use of social media, cyberbullying is now
well recognized as a serious public health problem af-
fecting children and adolescents [135]. It is defined as
“any behavior performed through electronic or digital
media by individuals or groups that repeatedly commu-
nicates hostile or aggressive messages intended to inflict
harm or discomfort on others” [136]. Ferrara et al. have
recently reviewed the data available in the literature
about these rising phenomena [137]. Actually, 20 to 40%
of children and adolescents have been victims of cyber-
bullying, with females and sexual minorities seemingly at
higher risk. The most common methods for electronic
bullying involve the use of instant messaging, chat
rooms, and e-mail. Importantly, in most cases the elec-
tronic bully victims do not know the perpetrator’s iden-
tity, indeed anonymity, by promoting disinhibition, can
lead to magnified aggression because the perpetrator
may feel out of reach and immune to retribution. In this
context, adolescents’ levels of social and emotional de-
velopment leave them vulnerable to peer pressure and at
the same time adolescents’ capacity to self-regulate is
limited, generally they realize the severity of the situation
after the effects have already occurred [138]. The motiv-
ation behind cyberbullying seems to be lack of confi-
dence or the desire to feel better about themselves, a
desire for control, finding it entertaining and retaliation,
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internet addiction. In cyberbullying, differently of trad-
itional bullying, aggressive behaviors occur at any given
time of the day, therefore the persistence of the bullying
behaviors may result in even stronger negative outcomes
than traditional bullying [136, 138]. Cyberbullying could
lead to new onset psychological symptoms, somatic symp-
toms of unclear aetiology or a drop in academic perform-
ance. It seems to be that victims of cyberbullying have
lower self-esteem, higher levels of depression, behavioral
problems, substance abuse and experience significant life
challenges [136, 138] which could result in suicidal behav-
ior. Ferrara et al. between January 2011 and December
2013 identified 55 cases of suicide among Italian children
and young adults aged less than18-years, and found that
the second most frequent known cause of suicide is bully-
ing [139]. In Italy, 2015 ISTAT data show that, among the
media devices adolescent users, the 5.9% report being vic-
tims of cyberbullying [140]. As several suicides were
linked to cyberbullying, the Italian Parliament has ap-
proved the so-called “anti-cyberbullying law” which makes
it illegal to use the Internet to offend, slander, threaten or
steal the identity of a minor, and ensure victims and their
parents to demand that websites hosting abusive content
is removed within 48 h [141]..
Seizures are not uncommon clinical manifestations in
childhood. The term epilepsy defines the recurrences of
two or more unprovoked seizures. Seizures starting in
the first year of life including the neonatal period might
have a favorable course, such as in infants presenting
with Benign Familial Neonatal Epilepsy (BFNE), Febrile
Seizures simplex (FSs) and Acute Symptomatic Seizures
(ASS). However, in some cases, the onset of seizures at
birth or in the first months of life have a dramatic evolu-
tion with severe cerebral impairment such as “epileptic
encephalopathies”.
Pavone et al. provided an updated review of the condi-
tions associated with seizures in the first year of life
[142]. BFNE is a condition inherited as an autosomal
dominant trait (mutation in the KCN gene, chromosome
20q13.33) and is characterized by seizures in the first
days of life in otherwise healthy looking babies and are
typically associated with a family history of neonatal
seizures, neonatal prognosis is usually benign and the
seizures tend to gradually disappear within the first
months of life [143]. ASS is defined as a clinical seizure
occurring at the time of a systemic insult or in close
temporal association with a documented brain insult
[144], they might follow trauma, intoxication, or anom-
alous administration of drugs or they could be induced
by electrolytic dysregulation (acute hypoglycemia, hypo-
calcemia, and hyponatremia). The occurrence of the
ASS is particularly high in the infantile period since, at
this age the brain seems to be more susceptible to suchinsults. The seizures present most frequently as motor
tonic-clonic generalized types and they usually have be-
nign course. FS are the most common convulsive mani-
festations in childhood, FSs are defined as a short (< 15
min.) generalized seizures, not recurring within 24 h
which occur during a febrile illness not resulting from
an acute disease of the nervous system, in a child aged
between 6months and 5 years, with no neurologic defi-
cits and no previous afebrile seizures [145]. Intravenous,
intramuscular, buccal, intranasal or rectal benzodiaze-
pines are administered to stop the crises while prophy-
lactic pharmacologic treatment is not advised [146].
Febrile Seizures complex (FSc) are focal, or general-
ized, and prolonged seizures lasting more than 15min,
recurrence can happen within 24 h in the course of the
same febrile episode, the temperature might not be ele-
vated. Moreover, the crises might be associated with
post-ictal neurologic abnormalities, most frequently
post-ictal palsy, or manifest in subjects with previous
neurologic deficits. They might be present in alternation
with afebrile seizures, or in members of a family affected
by Genetic Epilepsy with Febrile Seizures plus (GEFS+,
autosomal dominant disorder characterized by muta-
tions of the gene SCN2A or less frequently of SCN1B)
[147]. Febrile status epilepticus might also be recorded.
The acute treatment is based on the use of benzodiaze-
pines. In FSc, prophylactic treatment might be useful in
reducing the frequency and the duration of the crises
but is not considered able to prevent the onset of subse-
quent epileptic seizures [148].Nutrition
1– obesity; 2 – dietary habits; 3 – malnutrition
Obesity is a major problem in Western Societies. The
position statement on obesity in children and adoles-
cents of Italian Society of Pediatrics stated the diagnostic
criteria for defining obesity according to World Health
Organization reference curves and ascribed the specific
causes of secondary obesity (endocrine, hypothalamic,
genetic, iatrogenic) [149]. Moreover, obesity comorbidi-
ties have been evaluated, such as hypertension by the
definition of the blood pressure values; dyslipidemia with
the indication for the oral glucose tolerance test in chil-
dren and adolescents with overweight or obesity; poly-
cystic ovary syndrome; gastrointestinal, renal, orthopedic
or respiratory complication. Dietary advices have been
fulfilled showing a variety of dietary regimens associated
to physical exercise. The indicators of successful treat-
ment are the BMI standard deviation scores, and in case
of low weight loss, other behavioral indicators. If the
lifestyle-based intervention, pharmacological treatment
or surgery should be used, including orlistat that repre-
sents the only drug available for children and bariatric
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all other therapies.
Subcutaneous adiposity is correlated with major health
diseases and reduced life expectancy [150]. Visceral fat
accumulation is generally associated with insulin resist-
ance and hyperglycemia, dyslipidemia and hypertension,
all together called metabolic syndrome. This syndrome
occurs in 31% of obese patients and it is related to type
2 diabetes, coronary heart disease and cerebrovascular
disorders, named “noncommunicable diseases”.
The pre-natal period since conception and further-
more the whole first year of life are crucial for control-
ling obesity risk in the life, so it is important to promote
a healthy lifestyle since this period called “the first 1000
days of life” [151]. Beneficial and possibly beneficial in-
terventions during pregnancy aimed at reducing child-
hood obesity are: balanced energy/protein supplements,
low glycemic index dietary recommendations, dietary
counseling alone or supported by physical activity or su-
pervised exercise. An alternative approach to weaning,
named baby-led weaning has been proposed for prevent-
ing obesity. Baby-led weaning [152] consists in offering
to infants directly whole pieces of food that put them-
selves in their mouth during family mealtimes from 6
month of age. In this way the child himself can decide
and control the quality and the quantity of food and the
speed to eat. It may promote the preference of a larger
choices of food because of the distinctive tastes of pro-
posed foods. Moreover, it can be in line with the recent
recommendations of the “early” introduction (after 4
months of age and before 12 months) of all foods, in-
cluding allergenic ones, to prevent the development of
food allergies [153]. However, there is an augmented risk
of choking and gagging, because there are variations in
age of babies for developing the skills of chewing, biting
and swallowing [154]. This means that frequently babies
continue milk formulas with the risk of inadequate iron
and energy intake and growth faltering. Regarding pre-
vention of obesity onset, no difference in Body Mass
Index has been found at 24 months [155].
A three-day record about the nutrient’s intake has
been composed by parents of 443 Italian children during
the first year of life (age 6.4–131 months) [36]. Interest-
ingly, most of children exceeded in the doses of protein
intake, simple carbohydrates and saturated fats above
the limits of the Italian Dietary Reference Values, with a
low intake of fiber and polyunsaturated fats. Regarding
micronutrients, the vitamin D intake was very low in all
age groups. Early interventions to support healthy life-
style habits are essential to ensure long term healthy
outcomes. To reduce the risk of noncommunicable
diseases several healthy advices during the first years of
life have been shown significant, such as breastfeeding,
using lower protein formulas for formula-fed infants,increasing fruit and vegetables and reducing junk foods
and sugar-sweetened drinks [156]. With as much
importance, physical activity interventions since peri-
conception and pregnancy period to childhood are effi-
cacious to reduce the risk of non-communicable diseases
in childhood [157].
Also developing countries are affected by overweight/
obesity. Particularly, in Ethiopia overweight and/or obes-
ity are frequent among school-aged children, revealing a
prevalence of 11.9% in a study from Bahir Dar City
[158]. Risk factors for obesity were higher wealth status,
dietary habits (fast food intake, low fruit and vegetable
use), and sedentary lifestyle.
From the other side of the coin, in the developing
countries acute severe malnutrition represent a major
health burden [159]. Several indicators have been identi-
fied to define the risk of malnutrition in childhood.
Childhood acute malnutrition is linked with the number
of children in the household, unprotected drinking water
sources, latrine availability, hand washing practice before
food preparation and child feeding, childhood diarrheal
disease, and number of vaccinations [160]. In fact, re-
peated diarrhea attacks and infections leads to weight
loss and compromise a child’s nutritional status. More-
over, the mother’s age at birth, birth interval, socioeco-
nomic status, father’s educational level and starting
complementary feeding at the age of 6 months are im-
portant determinants of severe acute malnutrition
among children from Nepal [161].
Interventions to prevent malnutrition have been devel-
oped. A supportive supervision trial has been tested with
the aim of achieving higher adherence to guidelines and
good quality of care at outpatient level for malnourished
children [162]. This approach has been shown effica-
cious in terms of cure rate and correctness in comple-
mentary treatment in six health centers of Uganda. In
Southern Ethiopia School Feeding Program [163]
showed positive effects on the mean BMI-for-age, sig-
nificant increase of height-for-age and improvements in
the dietary diversity and class attendance.
Surgery
1 - day surgery procedures 2 - esophageal atresia
The Italian Society of Pediatric Surgery (SICP) and The
Italian Society of Pediatric Anesthesia (SARNePI) pro-
duced EBM-guidelines on the feasibility of day surgery
in relation to different pediatric surgical procedures
[164]. Children represent an interesting model for day-
case management since they commonly have few co-
morbidities and most pediatric operations are proce-
dures suitable for day surgery. The main aspects of the
pre-operative assessment involve clinical factor with
structured questionnaires and clinical evaluation, socio-
familiar factors to check a parental/environmental
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and discharge. An assessment of the pediatric operations
in day surgery, including enrollment, anesthesia and
discharge, have been reported. One of the most common
ambulatory surgical procedures in pediatric age is
tonsillectomy with or without adenoidectomy, since it
represents the first-line treatment for patients with ob-
structive sleep-disordered breathing (oSDB). Ambulatory
tonsillectomies in the United States in 2010 have been
estimated 339,000 in children (median age 7.8 years)
[165]. Inpatient procedures were associated with youn-
ger age (< 3 years) and patients affected by oSDB. Peri-
operative events such as apnea, hypoxia, or bleeding
occurred 7.8% of cases.
The prescription of drugs for analgesia after surgical
procedures warrant careful consideration also because
they can elicit anaphylactic reactions [166]. In particular,
the use of opioids in pediatric population after surgical
procedures still needs standardization. A retrospective
study observed that opioids were prescribed in 37.4% of
cases on discharge after 329 pediatric ambulatory hernia
surgery procedures [167]. Doses varied from 0 to a max-
imum of 33 doses between surgeons for the same pro-
cedure. Moreover, an increased probability of opioid
prescription was associated with increasing patient age
with a prevalence of opioids prescription of 1.5% among
children under 1 year of age and 91.6% in children aged
15 to 17 years.
Esophageal atresia (EA) is an anatomic variant that
may include a tracheoesophageal fistula and be corre-
lated to the complete stenosis of the esophagus. A recent
study recruited 67 newborns with EA classified accord-
ing to different clinical presentations: isolated EA; EA
plus a concomitant single malformation; VACTERL as-
sociation; and EA in the context of multiple congenital
anomalies [168]. Many evolution patterns have been
considered according to the mortality, the duration of
the total parental nutrition, the invasive mechanical ven-
tilation, or the corrected gestational age at discharge.
The most complex conditions were associated with
higher levels of intensive care.
A recent review of collected databases included 207
newborns with EA and/or tracheoesophageal fistula
(TEF) from 2008 to 2017 and showed the association of
laryngotracheal abnormalities (LTA) in 40% of cases
[169]. All patients underwent to flexible laryngotracheo-
scopy in order to analyze the impact of airway anomal-
ies. Infants with EA/TEF and LTA were characterized by
higher frequency of tracheostomy and increased mortal-
ity rate compared with those without LTA.
Severe tracheomalacia is frequently associated to EA/
TEF and characterized by dynamic airway collapse. It
needs to be treated with surgery at the time of initial EA
repair (primary treatment) or secondary treatment. Aretrospective review collected 118 patients with EA who
underwent posterior tracheopexy in Boston Children’s
Hospital for 4 years, showing that this procedure has sig-
nificant improvements in clinical symptoms and degree
of airway collapse on bronchoscopy [170]. Long-term
quality of life in patient with EA is often characterized
by physical limitations since the survival is increasing
over the last years. Surprisingly, among 17 German pa-
tients with EA aged 3.12 years, 93% of cases participated
regularly to physical education classes at school and 86%
of them in fitness events [171].
Conclusion
Last year, investigations have offered great progresses in
recognizing the pathomechanisms of pediatric diseases
and has unraveled different beneficial approaches. The
development of novel therapies has allowed not only an
improved disease management but also a change of the
natural history of diseases. Intensive attempts have been
made to identify risk factors that can be modified to pre-
vent the diseases. However, there are several unmet
needs, for example in understanding interaction between
genes and environment, better strategies for diagnostics,
response to treatment according to disease severity, and
primary prevention.
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